In tumour cells, mTOR up‐regulates PKM2 to promote aerobic glycolysis, which in turn (through HIF1 and c‐Myc) enhances cell survival in different oxygen and nutrient gradient microenvironments 36, 38. Here, MYC is linked to neoplasm.